Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells

Código QR

Decitabine activates type I interferon signaling to inhibit p53‐deficient myeloid malignant cells

Guardado en:

Detalles Bibliográficos
Autores principales:	Jiale Wu, Yuntong Li, Jiaqi Wu, Huaxin Song, Yigang Tang, Ni Yan, Lili Wu, Sujiang Zhang, ChunKang Chang, Min Lu
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/926e064d1d464ddf9ab10186d85b09c2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia
por: Briot T, et al.
Publicado: (2017)

Use of Azacitidine or Decitabine for the Up-Front Setting in Acute Myeloid Leukaemia: A Systematic Review and Meta-Analysis
por: Miriam Saiz-Rodríguez, et al.
Publicado: (2021)

Loss of Asxl2 leads to myeloid malignancies in mice
por: Jianping Li, et al.
Publicado: (2017)

Differentiation therapy for myeloid malignancies: beyond cytotoxicity
por: Ryan J. Stubbins, et al.
Publicado: (2021)

Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
por: Sara Small, et al.
Publicado: (2021)

Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming
por: Yao Wang, et al.
Publicado: (2021)

Experimental and thermodynamic modeling decitabine anti cancer drug solubility in supercritical carbon dioxide
por: Mahboubeh Pishnamazi, et al.
Publicado: (2021)

Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood
por: Pia Michler, et al.
Publicado: (2021)

Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis
por: Thomas P Burke, et al.
Publicado: (2021)

Assessment of TP53 mutations in benign and malignant salivary gland neoplasms.
por: Carolina Cavaliéri Gomes, et al.
Publicado: (2012)

Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia
por: Yasutaka Hayashi, et al.
Publicado: (2019)

EBI2 is a negative regulator of type I interferons in plasmacytoid and myeloid dendritic cells.
por: Eugene Y Chiang, et al.
Publicado: (2013)

Segmentation of Gastric Computerized Tomography Images under Intelligent Algorithms in Evaluation of Efficacy of Decitabine Combined with Paclitaxel in Treatment of Gastric Cancer
por: Zhenghui Ge, et al.
Publicado: (2021)

Type I interferon-mediated autoinflammation due to DNase II deficiency
por: Mathieu P. Rodero, et al.
Publicado: (2017)

TP53 isoform junction reads based analysis in malignant and normal contexts
por: Suleyman Vural, et al.
Publicado: (2021)

TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells
por: Selvakumar Anbalagan, et al.
Publicado: (2021)

Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system.
por: Debasis Nayak, et al.
Publicado: (2013)

Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells
por: Camilla M. Grunewald, et al.
Publicado: (2021)

TRIM25 contributes to the malignancy of acute myeloid leukemia and is negatively regulated by microRNA-137
por: Wang Sheng, et al.
Publicado: (2020)

Development of a genetic sensor that eliminates p53 deficient cells
por: Jovan Mircetic, et al.
Publicado: (2017)

Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway
por: Kevin Alicea-Torres, et al.
Publicado: (2021)

STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection
por: Siyuan Ding, et al.
Publicado: (2018)

Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy
por: Matthias Kettwig, et al.
Publicado: (2021)

Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis.
por: Jeffrey C Francis, et al.
Publicado: (2010)

Concurrent ductal carcinoma in-situ and malignant phyllodes with tp53 mutation in an 11-year-old
por: Cameron F. Leveille, et al.
Publicado: (2021)

MG53 suppresses interferon-β and inflammation via regulation of ryanodine receptor-mediated intracellular calcium signaling
por: Matthew Sermersheim, et al.
Publicado: (2020)

G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma
por: Yuxiang Wang, et al.
Publicado: (2019)

The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells
por: Xiao Gao, et al.
Publicado: (2020)

Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2.
por: Thorsten Klampfl, et al.
Publicado: (2013)

DHAV-1 Blocks the Signaling Pathway Upstream of Type I Interferon by Inhibiting the Interferon Regulatory Factor 7 Protein
por: Yalan Lai, et al.
Publicado: (2021)

Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profile.
por: Anna Kreutzman, et al.
Publicado: (2011)

Suppression of autophagy promotes fibroblast activation in p53-deficient colorectal cancer cells
por: Takanori Inoue, et al.
Publicado: (2021)

ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53
por: Edmund Osei Kuffour, et al.
Publicado: (2019)

Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair
por: Justin Zonneville, et al.
Publicado: (2021)

The first case of acute myeloid leukaemia/myeloid sarcoma with cytokeratin expression on blasts diagnosed on urine specimen
por: Claire Comerford, et al.
Publicado: (2021)

Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion
por: Antonia Marazioti, et al.
Publicado: (2018)

STAT6 Deficiency Attenuates Myeloid Fibroblast Activation and Macrophage Polarization in Experimental Folic Acid Nephropathy
por: Baihai Jiao, et al.
Publicado: (2021)

Sexual and Vertical Transmission of Zika Virus in anti-interferon receptor-treated Rag1-deficient mice
por: Clayton W. Winkler, et al.
Publicado: (2017)

Downregulation of Interferon-β and Inhibition of TLR3 Expression are associated with Fatal Outcome of Severe Fever with Thrombocytopenia Syndrome
por: Peixin Song, et al.
Publicado: (2017)

Mutational signatures in tumours induced by high and low energy radiation in Trp53 deficient mice
por: Yun Rose Li, et al.
Publicado: (2020)